FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition as granules containing core and enterosoluble envelope. Core comprises 80-100% of didanosine, 0-10% of binding agent taken in the ratio of enterosoluble envelope and core from 0.05:1 to 0.6:1. Granules show the enhanced chemical stability. EFFECT: improved properties of composition. 27 cl, 1 dwg, 2 ex
Authors
Dates
2003-01-27—Published
1998-08-04—Filed